If you have cancer or know someone with cancer they may want to learn about our current clinical trial. This new national trial is changing the way cancer research is done.
MUSC is taking enrollment in this national study called NCI MATCH, offering another tool in the cancer arsenal. It gives a different opportunity to cancer patients who have tried at least one line of standard therapy or for whom no standard therapy exists.
The study doesn’t focus on the type of cancer a patient has but rather on the mutations and what drugs have been shown to treat that mutation, possibly halting a tumor’s growth.
You can read more about this unique study in our news article MUSC part of innovative national cancer trial.